home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

HIV Reveals Vulnerable Side

  February, 22 2007 9:37
your information resource in human molecular genetics
Researchers have snuck a detailed peek at the crystal structure of a known broadly neutralizing human immunodeficiency virus (HIV-1) antibody as it binds to a specific part of HIV-1. The find, reported in the 15 February 2007 issue of Nature (Vol. 445, No. 7129, pp. 732-737), is important because the binding site represents a chink in HIV's armour that could help guide future vaccine development.

HIV keeps one step ahead of the human immune system by mutating frequently and changing its shape. But certain parts of the virus must remain relatively unchanged so that it can continue to bind to and enter human cells. gp120, a glycoprotein that juts out from the surface of the virus and binds to CD4 receptor on host cells, is one such region, making it a target for vaccine development.

Peter D. Kwong and colleagues made variants of stable gp120 that could be recognized by antibodies. They then looked in detail at the binding of one antibody, called b12, to the glycoprotein and found that the antibody approaches in an orientation very similar to that of CD4. Although other antibodies bind at this sight, b12 is the only one that binds and neutralizes a relatively broad range of HIV-1 isolates, so the results may help explain why.


Peter D. Kwong (National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD, USA)
E-mail: pdkwong@nih.gov

(C) Nature press release.

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.